- Staat
- MI
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 13.03.2023
- Impfdatum
- 07.02.2022
- Beginn
- 10.02.2023
- Tage bis Beginn
- 368,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute myeloid leukaemia
Acute respiratory failure
Adrenal adenoma
Biopsy bone marrow abnormal
Blood aldosterone
Blood catecholamines
Blood culture negative
Blood smear test abnormal
COVID-19
Central venous catheterisation
Chemotherapy
Computerised tomogram abdomen abnormal
Computerised tomogram abnormal
Computerised tomogram neck
Computerised tomogram thorax abnormal
Cortisol free urine normal
Dehydroepiandrosterone test
Diuretic therapy
Symptomtext
Primary Care Physician at Discharge: DO Hematologist/Oncologist: Dr. Admission Date: 2/10/2023 Discharge Date: 03/11/2023 Patient's Discharge Disposition: Home in stable condition. This is a a 46 yo female with a history of ADHD who presented to the ED on 2/10/23 with findings of elevated WBC and concerns for acute leukemia. Peripheral smear on 2/10 was consistent with acute leukemia. On presentation she had anterior cervical lymphadenopathy and concerns for sinusitis and tonsillitis. CT neck 2/10 showed several mildly enlarged level 1 and 2 lymph nodes as well as mildly prominent retropharyngeal lymph nodes findings concerning for possible tonsillitis/sinusitis. The patient was found to be positive for Covid-19 on admisison. She was treated with dex 2/10-2/15 and Remdesivir and remained stable. Bone marrow biopsy done 2/13 (in IR) was positive for AML, normal kayotype, FLT3-TKD mutated and NPM! Mutated. Panorex with no acute findings. ECHO with LVEF 64%. Hepatitis and HIV were negative. HLA typing was sent. PICC line was placed 2/15. She started induction chemo on 2/15/23 with 7+3 and then started Rydapt/Midostaurin D8-21. Day 21 IR bone marrow done 3/7 showed approximately 80% cellular bone marrow, no evidence of leukemia. She did have recurrent sinus pain and neck swelling. CT sinus/neck on 3/5 showed pansinusitis, possible otomastoiditis. ENT did see her and did not have concern for acute mastoididits. Blood cultures were negative. ID was consulted. She was on broad spectrum antibiotics. . During her nadir she also had neutropenic fevers and recurrent acute hypoxemic respiratory failure. CT thorax 3/5 showed diffuse bilateral interstitial ground glass opacities. ECHO 3/5/23 showed an EF of 55%, previously was 64%. Pulmonary was consulted and felt respiratory failure related to fluid overload vs TRALI/TACO with frequent transfusions. She was started on IV lasix BID and had good results and improvement with diuresis. She developed a rash thought to be related to cefepime and ultimately improved once antibiotics were changed. She was treated with with merrem, vancomycin, micafungin, and nystatin through 3/10 when her counts recovered. ID recommended observing off antibiotics. At discharge they recommended ppx acyclovir but with negative bone marrow biopsy from Day 21 antifungal medications. She was also on IV steroids which will be quickly tapered down at discharge. She has been weaned off O2 inpatient. The patient's counts recovered with no evidence of leukemia on D21 Bone marrow biopsy the patient is stable for discharge home today. PICC line was removed. She lives in the area and would like to get labs on Tuesdays/Thursdays in the office but will follow-up with Dr. at clinic. Per weekend attending she will need another IR bone marrow biopsy next week now that her counts have recovered. We will arrange outpatient IR bone marrow biopsy and f/u with Dr. after that is done. She is discharging home in stable condition. Incidental findings this admission: -CT sinuses 3/5 showed prominence of the sella- probably related to empty sella-- patient was asymptomatic with these findings. -CT AP 2/10 showed splenomegaly, multiple vascular lesions throughout liver-likely hemangiomas and MRI abdomen 2/14 showed focal nodular hyperplasia in the right lobe of liver. Has had Mild LFT elevation, but stable. -CT AP 2/14 showed complex partially exophytic cyst at the upper pole of right kidney, ? Bosniak III cyst. Urology plans f/u in 4 months to discuss further treatment plan. -MRI 2/14 right adrenal adenoma- urology evaluated-- 24h urine cortisol (<3.4), plasma fractionated metanephrines (<0.20), DHEA sulfate (low at 12.4) and aldosterone (10.7) level
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 29,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Leukocytosis Acute myeloid leukemia not having achieved remission Neutropenic fever Morbid obesity with body mass index (BMI) of 50.0 to 59.9 in adult Tobacco use Adult ADHD Mucositis due to chemotherapy Alternating constipation and diarrhea Counseling regarding advanced care planning and goals of care Dysphagia with left side facial/neck swelling. Acute respiratory failure with hypoxia hx of COVID-19 Bilateral pulmonary infiltrates on Imaging
- Andere Medikamente
- acyclovir (ZOVIRAX) 200 MG capsule amLODIPine (NORVASC) 2.5 MG tablet benzonatate (TESSALON) 100 MG capsule furosemide (LASIX) 20 MG tablet guaiFENesin (MUCINEX) 600 MG 12 hr tablet lidocaine viscous (XYLOCAINE) 2 % solution loperamide (IMO
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 07.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Headache
Pain in extremity
Peripheral swelling
Pyrexia
Tissue injury
Symptomtext
Patient began to have fever, headache, arm swelling on 5/4/22. Then presented with deep tissue injury and arm pain that began on 5/6/22 .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 18.09.2023
- Impfdatum
- 21.02.2023
- Beginn
- 21.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No additional AE reported.; Patient was administered expired VAQTA; This spontaneous report was received from Pharmacist and refers to an unknown patient of an unknown age or gender. The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported. On 21-FEB-2023, the patient was vaccinated with an expired vaccine of hepatitis a vaccine, inactivated (VAQTA) lot #U021561, expiration date: 14-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired vaccine used), it was stated that No Temperature Excursion reported for Affected Product prior the administration of the vaccine. No additional adverse event was reported. This case was considered as non-valid due to lack of patient identifiers. Follow-up information has been received from the pharmacist on 11-SEP-2023. The patient's demographic information was updated. The case was regarding a 87-years-old male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. The previously reported expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) was administered intramuscularly. It was reported the patient and primary physician were informed of the incident and that the patient had no side effect or adverse reactions from the expired dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 16.03.2023
- Beginn
- 16.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Expired vaccine administered
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.03.2023
- Impfdatum
- 10.03.2023
- Beginn
- 10.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; an expired dose of VAQTA to a patient on 10MAR2023; This spontaneous report was received from a Medical Assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 10-MAR-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 dosage form, lot #U021561, expiration date: 14-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). The reporter confirmed the product was not involved in a temperature excursion and was stored according to the recommended storage range until administration. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 20.03.2023
- Impfdatum
- 23.02.2023
- Beginn
- 23.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs; LPN calling to report that expired lot of VAQTA ADULT (EXP 1/14/2023) was administered on 2/23/2023; This spontaneous report was received from licensed practical nurse and refers to a 20-year-old male.The patients' concurrent conditions, medical history, concomitant therapies and historical drug were not provided. On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter, lot #U021561, expiration date: 14-JAN-2023 (expired product administered), administered intramuscularly for prophylaxis (strength was not provided). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.02.2023
- Impfdatum
- 26.01.2023
- Beginn
- 26.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix adult) (batch number U021561, expiry date 14th January 2023) for prophylaxis. On 26th January 2023, the patient received Havrix adult. On 26th January 2023, unknown after receiving Havrix adult, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's Comments: The reporter mentioned that one of his/her nurses inadvertently administered an expired Adult Hepatitis A vaccine. The reporter was looking for guidance as to whether they need to re-vaccinate the patient. No other details provided The reporter consented to follow up via web form. No other details provided. Additional Supportive Information: the patient inadvertently received expired dose of Hepatitis A adult vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 16.01.2023
- Beginn
- 16.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No additional AE/PQC reported; expired VAQTA was administered to a patient; This spontaneous report was received from a medical assistant and referred to a 66-year-old male patient. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported. On 16-JAN-2023, the expired hepatitis a vaccine, inactivated (VAQTA) intramuscular injection was administered to the patient for prophylaxis (lot #U021561, expiration date: 14-JAN-2023; strength, dose and route of administration were not provided) (expired product administered). No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.02.2023
- Impfdatum
- -
- Beginn
- 27.01.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Healthcare provider reports the administration of an expired dose of VAQTA to a patient on 27-JAN-2023.; This spontaneous report has been received from a medical assistant regarding a patient of unknown age and gender. Patient's pertinent medical history, drug reactions and allergies and concomitant medication were unknown by reporter. On 27-JAN-2023, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA), intramuscular injection, administered as prophylaxis, (dose, strength, route of administration, and anatomical location were not provided; lot number U021561 had been verified to be a valid number; expiration date was reported and established as 14-JAN-2023) (expired vaccine used). No additional adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.02.2023
- Impfdatum
- 19.01.2023
- Beginn
- 19.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Medical assistant reports patient was accidently administered an expired dose of VAQTA on Jan 19, 2023. Product expired on Jan 14, 2023. Product had no prior temperature excursions. No further information provided. No additional AE reported. No PQC r; This spontaneous report was received from medical assistant and refers to an unknown age and gender patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions allergies, and concomitant therapies were not reported. On 19-JAN-2023, the patient was accidently administered an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, once, lot #U021561, expiration date: 14-JAN-2023, administered intramuscularly (strength, dose and indication were not provided) (expired product administered). It was mentioned that the product had no prior temperature excursions. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 31.01.2023
- Impfdatum
- 25.01.2023
- Beginn
- 25.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; Nurse Practitioner called and reported that a dose of VAQTA expired on 14JAN2023 and was administered on 25JAN2023. The product had no temperature excursions through date of administration. No additional AE reported. No PQC reported. No additional in; This spontaneous report was received from a nurse prescriber regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot #U021561, expiration date: 14-JAN-2023) (Expired product administered) for prophylaxis (strength, dose, dose number, anatomical location and route of administration were not provided). It was reported that the product had no temperature excursions and no additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 16.01.2023
- Beginn
- 16.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; A HCP called to report that an expired dose of VAQTA was administered to a patient; This spontaneous report was received from a nurse, referring to a patient with unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapy and drug reactions/allergies were not reported. On 16-JAN-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot number U021561 has been verified to be a valid lot number, expiration date was reported as 14-JAN-2023, dose, route and anatomical location were not provided) for prophylaxis (expired product administered). It has been confirmed no adverse effects were noted. No additional adverse event (AE) reported (no adverse event). This report was considered as non-valid due to the lack of the patient's identifiers. Follow up information has been received from the nurse, referring to a 23-year-old female patient on 24-JAN-2023. The patient had no ill effects from administration. On 16-JAN-2023, the patient was vaccinated with the correct hepatitis a vaccine, inactivated (VAQTA) (anatomical location was reported as left deltoid) via intramuscularly at private doctor's office/hospital. The hepatitis a vaccine, inactivated (VAQTA) expired two days prior to administration. No concerned with the efficacy of the vaccine administered. This report became to valid.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.01.2023
- Impfdatum
- 24.01.2023
- Beginn
- 24.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; expired VAQTA was administered to one patient. Product expired 1/14/2023 and was administered today 1/24/2023.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information of the patient's medical history, concurrent condition and concomitant therapy was not reported. On 24-JAN-2023 (also reported as today), the patient was administrated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection 1 ml (lot #U021561, expiration date: 14-JAN-2023, strength, anatomical location and route of administration were not provided) for prophylaxis (expired product administered). The product was stored according to prescribing information through the date of administration. No additional adverse event (AE) details were available. No additional AE was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.01.2023
- Impfdatum
- 16.01.2023
- Beginn
- 16.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported.; Customer reported expired VAQTA was administered to a patient.; This spontaneous report has been received from a nurse referring to a 57-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported. On 16-JAN-2023 the patient has vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA SYRINGE (DEVICE)) 0.5 milligrams, for prophylaxis (lot #U021561 had been verified to be a valid number; expiration date 14-JAN-2023, and upon internal validation established as the same date) (vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported) (expired product administered). There was no adverse effect reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 25.01.2023
- Impfdatum
- 25.01.2023
- Beginn
- 25.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Adverse event: inadvertently administered expired Hep A vaccine. APRN inadvertently administered an expired vaccine to her patient because she failed to verify the expiration date on the vaccine vial before administration. Patient was monitored for 15 minutes after administration and did not experiences any adverse reactions to vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 22.01.2023
- Impfdatum
- 21.01.2023
- Beginn
- 21.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
It was noted after administration and after the patient had left, that the vaccine was expired by one week
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 09.01.2023
- Impfdatum
- 13.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Patient received Hep A vaccine #2 and Hep B vaccine #3 on 12/8/22. Patient then received another Hep A and Hep B vaccine on 12/13/22 by a different nurse. No report signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Olanzapine ODT 20mg Hydroxyzine pamoate 25mg Ibuprofen 400mg Clonidine 0.1mg Abilify 10mg
- Allergien
- Methylphenidate
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 22.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
The patient received a Heplisav-B vaccine on 9/22/2022 that had expired on 9/17/2022. The patient did not experience any adverse events from the expired vaccine. She was notified of the incident.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 16,0
- Geschlecht
- U
- Eingang
- 11.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Client was given one dose of adult Hep A vaccine instead of a pediatric dose. Mother advised and will be assessing for adverse signs/symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Client was given dose of adult vaccine instead of pediatric dosage. Mother advised and will be assessing for adverse reaction signs/symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 11.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Client was given adult dose of Hep A vaccine instead of pediatric dose. Clients mother was notified and will be assessing for signs/symptoms of adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,1
- Geschlecht
- M
- Eingang
- 10.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Symptomtext
No reported adverse reaction currently, discovered patient given adult dose of Hep A so received 1 ml and was due for 0.5 ml
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No symptoms or adverse reaction reported. Patient received adult dose of Hepatitis A vaccine instead of pediatric dose. (Packaging similar and print on box and syringe very small).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- None at this time
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 05.05.2022
- Impfdatum
- 05.05.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Pt was in for a visit and stated he needed his 2nd Hep A vaccine. The immunization screen was showing only 1 previous dose and the forcast was showing he was due for his 2nd Hep A. The vaccine was ordered and administered per protocol. After pt left the clinic, I noticed on the front screen that the patient had received a 2nd Hep A on 8/10/20 that was never entered on his immunization screen. Therefore the patient received an extra dose of Hep A.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- no tests were required. Pt tolerated the vaccine well.
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKDA
- Vorherige Impfungen
- -